Search results for "Conjugate"

showing 10 items of 644 documents

Supramolecular assembly of functional peptide-polymer conjugates.

2019

The following review gives an overview about synthetic peptide-polymer conjugates as macromolecular building blocks and their self-assembly into a variety of supramolecular architectures, from supramolecular polymer chains, to anisotropic 1D arrays, 2D layers, and more complex 3D networks. A selection of recent literature examples using linear, coiled-coil and cyclic peptide motifs is provided. The reversible nature of the unimer-to-supramolecular polymer transition provides unique opportunities to investigate mechanistic aspects of the supramolecular assembly, with respect to the thermodynamic or kinetic parameters and furthermore provides exciting opportunities for non-equilibrium assembl…

Macromolecular SubstancesPolymersSupramolecular chemistryNanotechnologymacromolecular substances02 engineering and technology010402 general chemistry01 natural sciencesBiochemistrySupramolecular assemblyMoleculeHumansPhysical and Theoretical Chemistrychemistry.chemical_classificationMolecular StructureChemistryOrganic Chemistrytechnology industry and agriculturePolymer021001 nanoscience & nanotechnology0104 chemical sciencesSupramolecular polymers0210 nano-technologyPeptidesFunction (biology)MacromoleculeConjugateOrganicbiomolecular chemistry
researchProduct

Calorimetric investigation of the interaction between a macromolecular prodrug of diflunisal and human platelets

1995

The thermal effect due to the interaction between human platelets and α,β poly(N-hydroxy-ethyl)-DL-aspartamide (PHEA) or the PHEA-Diflunisal conjugate was measured by the calorimetric technique at 25°C. The experimental data confirm that PHEA is a biocompatible macromolecule and that its conjugate influences the physiological activity of human platelets.

Macromolecular prodrugsStereochemistryChemistryThermal effectBiophysicsmedicineDiflunisalPlateletProdrugIn vitroMacromoleculemedicine.drugConjugateJournal of thermal analysis
researchProduct

Synthesis of glycopeptides and neoglycoproteins containing the fucosylated linkage region of N-glycoproteins.

1994

Abstract N-Glycoproteins fucosylated in the core region occur in tumor membranes and virus envelopes. Partial structures of such N-glycoproteins containing fucosylated chitobiosyl asparagine conjugates were synthesized using the allyloxycarbonyl (Aloc) and the tert-butyl ester protecting groups in the peptide portion. As the α-fucosidic bond of the conjugates revealed to be very sensitive to acids when carrying ether-type protecting groups, a method for exchanging the protecting groups of the fucose portion of saccharides was developed. Conjugates containing O-acetyl protected fucose proved to be stable against acids used in glycopeptide syntheses. These methods were applied in the synthesi…

Magnetic Resonance SpectroscopyGlycoconjugateClinical BiochemistryMolecular Sequence DataPharmaceutical SciencePeptideChitobioseDisaccharidesBiochemistryFucosechemistry.chemical_compoundViral ProteinsViral envelopeDrug DiscoveryAsparagineAmino Acid SequenceBovine serum albuminMolecular BiologyGlucansFucoseGlycoproteinschemistry.chemical_classificationbiologyOrganic ChemistryGlycopeptidesFucosyltransferasesGlycopeptidechemistryBiochemistryCarbohydrate Sequencebiology.proteinMolecular MedicineAsparagineBioorganicmedicinal chemistry
researchProduct

Fluoropolymer Based on a Polyaspartamide containing 1,2,4-Oxadiazole Units: A Potential Artificial Oxygen (O2) Carrier

2007

Abstract In this preliminary work we have prepared a fluorinated polymer capable of solubilizing an appreciable amount of O(2) and, at the same time, maintaining a higher water solubility than perfluoroalkanes investigated as injectable O(2) carriers. In particular, we describe the synthesis and characterization of a new macromolecular conjugate obtained by derivatization of alpha,beta-poly(N-2-hydroxyethyl)-DL-aspartamide (PHEA) with 5-pentafluorophenyl-3-perfluoroheptyl-1,2,4-oxadiazole, called PHEA-F. This new water soluble fluoropolymer was prepared in high yield using a simple procedure. It was characterized by FT-IR and UV-vis spectrophotometry, (19)F-NMR and SEC measurements. O(2) so…

Magnetic Resonance SpectroscopyPolymers and PlasticsBiocompatibilityMacromolecular SubstancesOxadiazoleBioengineeringBiomaterialschemistry.chemical_compoundSpectroscopy Fourier Transform InfraredMaterials ChemistryOrganic chemistrySolubilityDerivatizationAqueous solutionMolecular StructureTemperatureHaemolysisOxygenFluorocarbon PolymerschemistryFluoropolymerSpectrophotometry UltravioletPeptidesBiotechnologyConjugateNuclear chemistryMacromolecular Bioscience
researchProduct

Galactosylated micelles for a ribavirin prodrug targeting to hepatocytes.

2013

Polymeric micelles potentially able to carry to hepatocytes a ribavirin (RBV) prodrug, exploiting the presence of carbohydrate receptors, that is, ASGPR, were prepared starting from a galactosylated polylactide-polyaminoacid conjugate. This latter was obtained by chemical reaction of α,β-poly(N-2-hydroxyethyl) (2-aminoethylcarbamate)-dl-aspartamide (PHEA-EDA) with polylactic acid (PLA), and subsequent reaction with lactose, obtaining PHEA-EDA-PLA-GAL copolymer. To enhance the entrapment into obtained nanostructures, a hydrophobic RBV prodrug, that is, RBV tripalmitate, was synthesized and its capability to release RBV in the presence of an adequate enzymatic activity was demonstrated. Liver…

Magnetic Resonance SpectroscopyPolymers and PlasticsBioengineeringMicelleAntiviral AgentsBiomaterialschemistry.chemical_compoundNon-competitive inhibitionPolylactic acidRibavirinSpectroscopy Fourier Transform InfraredMaterials ChemistryCopolymerOrganic chemistryHumansProdrugsMicellesChemistrytechnology industry and agricultureGalactoseHep G2 CellsProdrugCarbohydrateCombinatorial chemistryIn vitroLiverSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoGalactosylated polymeric micelles hepatic cell-targeted carriers active targeting ribavirin tripalmitate hepatitis C.ConjugateBiomacromolecules
researchProduct

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for …

2015

Background Up-to-date evidence on levels and trends for age-sex-specific all-cause and cause-specific mortality is essential for the formation of global, regional, and national health policies. In the Global Burden of Disease Study 2013 (GBD 2013) we estimated yearly deaths for 188 countries between 1990, and 2013. We used the results to assess whether there is epidemiological convergence across countries. Methods We estimated age-sex-specific all-cause mortality using the GBD 2010 methods with some refinements to improve accuracy applied to an updated database of vital registration, survey, and census data. We generally estimated cause of death as in the GBD 2010. Key improvements included…

MaleAgingPediatricsNutrition and DiseaseDatabases FactualDisease030204 cardiovascular system & hematologyGlobal HealthMedical and Health SciencesDOUBLE-BLIND0302 clinical medicineAdolescent; Adult; Aged; Aged 80 and over; Cause of Death; Child; Child Mortality; Child Preschool; Databases Factual; Female; Global Health; Humans; Infant; Infant Newborn; Life Expectancy; Life Tables; Male; Middle Aged; Models Statistical; Mortality; Sex Distribution; Young AdultModelsVoeding en ZiekteCause of DeathEpidemiologyGlobal health80 and over2.2 Factors relating to the physical environmentLife Tables030212 general & internal medicineAetiologyChildINFLUENZAE TYPE-B11 Medical and Health SciencesCause of deathPediatricAged 80 and overPLACEBO-CONTROLLED-TRIALLife TableMortality rateMedicine (all)1. No povertyGeneral MedicineCHILDHOOD PNEUMONIAMiddle AgedStatistical3. Good healthInfectious DiseasesChild PreschoolPNEUMOCOCCAL CONJUGATE VACCINEChild MortalityFemaleInfectionLife Sciences & BiomedicineHumanAdultmedicine.medical_specialtyAdolescentINTEGRATED APPROACHCHILDREN YOUNGER187 COUNTRIESDatabase03 medical and health sciencesDatabasesYoung AdultMedicine General & InternalLife ExpectancyGeneral & Internal MedicinemedicineLife ScienceHumansMortalitySex DistributionPreschoolFactualVLAGAgedScience & TechnologyModels Statisticalbusiness.industryPreventionPOPULATION HEALTHInfant NewbornENTERIC MULTICENTERInfantGBD 2013 Mortality and Causes of Death CollaboratorsNewbornVerbal autopsyChild mortalityGood Health and Well BeingLife expectancyRISK-FACTORSbusiness2.4 Surveillance and distributionDemographyModel
researchProduct

Antibody persistence and immune memory 15 months after priming with an investigational tetravalent meningococcal tetanus toxoid conjugate vaccine (Me…

2012

The present extension study, conducted in children originally vaccinated at 12–14 mo or 3–5 y of age, assessed antibody persistence and immune memory induced by an investigational tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT). In the original study, participants were randomized to receive one dose of MenACWY-TT or licensed age-appropriate meningococcal control vaccines. Fifteen months post-vaccination, all participants underwent serum sampling to evaluate antibody persistence and participants previously vaccinated as toddlers received a polysaccharide challenge to assess immune memory development.   Exploratory comparisons showed that (…

MaleBlood Bactericidal ActivityImmunologyPriming (immunology)Meningococcal VaccinesMeningococcal vaccineNeisseria meningitidismedicine.disease_causeimmune memoryPersistence (computer science)meningococcal vaccinechildrenConjugate vaccinemedicineHumansImmunology and AllergytoddlersPharmacologyMicrobial Viabilitybiologybusiness.industryTetanusNeisseria meningitidisToxoidInfantSpecial Focus Short Reportpersistencemedicine.diseaseAntibodies BacterialVirologyChild PreschoolImmunologybiology.proteinFemaleAntibodytetanus toxoidbusinessImmunologic MemoryHuman Vaccines & Immunotherapeutics
researchProduct

SYNTHESIS, PHYSICO-CHEMICAL AND BIOLOGICAL CHARACTERIZATION OF A PACLITAXEL MACROMOLECULAR PRODRUG

2004

Paclitaxel was attached to poly(hydroxyethylaspartamide) via a succinic spacer arm by a two-step protocol: (1) synthesis of 2'-O-succinyl-paclitaxel; (2) synthesis of PHEA-2'-O-succinyl-paclitaxel. The 2'-O-succinyl-paclitaxel derivative and the macromolecular conjugate were characterized by UV, IR, NMR and mass spectrometry analysis. The reaction yields were over 95% and the purity of products over 98%. Paclitaxel release and degradation from 2'-O-succinyl-paclitaxel occurred at a faster rate at pH 5.5 than 7.4. After 30 h of incubation at pH 5.5 and 7.4 the released free paclitaxel was about 40 and 20%, respectively. In plasma both drug release and degradation were found to occur at a hig…

MaleChemical PhenomenaPaclitaxelMacromolecular SubstancesPharmaceutical Sciencechemistry.chemical_compoundMicePharmacokineticsIn vivoCell Line TumorOrganic chemistryAnimalsProdrugschemistry.chemical_classificationMice Inbred BALB CChromatographyBioconjugationChemistryChemistry PhysicalMacromolecular SubstancesBiological activityGeneral MedicineEnzymePaclitaxelPolymeric prodrug Polymer therapeutics Conjugation αβ-Poly(N-2-hydroxyethyl)-dl-aspartamide PaclitaxelSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDrug Screening Assays AntitumorBiotechnologyConjugate
researchProduct

Effects of Conjugated Linoleic Acid Associated With Endurance Exercise on Muscle Fibres and Peroxisome Proliferator-Activated Receptor γ Coactivator …

2016

Conjugated linoleic acid (CLA) has been reported to improve muscle hypertrophy, steroidogenesis, physical activity, and endurance capacity in mice, although the molecular mechanisms of its actions are not completely understood. The aim of the present study was to identify whether CLA alters the expression of any of the peroxisome proliferator-activated receptor γ coactivator 1α (PGC1α) isoforms, and to evaluate the possible existence of fibre-type-specific hypertrophy in the gastrocnemius and plantaris muscles. Mice were randomly assigned to one of four groups: placebo sedentary, CLA sedentary, placebo trained, or CLA trained. The CLA groups were gavaged with 35 μl per day of Tonalin® FFA 8…

MaleConjugatedPhysiologyClinical BiochemistryMuscle Fibers SkeletalMuscle FibersMiceLectinsPhysical Conditioning AnimalAnimalsProtein IsoformsLinoleic Acids ConjugatedInbred BALB CMice Inbred BALB CAnimalSettore BIO/16 - Anatomia UmanaAdenylate KinaseSkeletalCell BiologyPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPhysical ConditioningHindlimbMitochondriaLinoleic AcidsAdenylate Kinase; Animals; Dietary Supplements; Hindlimb; Lectins; Linoleic Acids Conjugated; Male; Mice Inbred BALB C; Mitochondria; Muscle Fibers Skeletal; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Protein Isoforms; Physical Conditioning Animal; Physiology; Clinical Biochemistry; Cell BiologyDietary SupplementsFat supplements
researchProduct

N-Valproyl-L-Phenylalanine as new potential antiepileptic drug: Synthesis, characterization and in vitro studies on stability, toxicity and anticonvu…

2013

Valproic acid (VPA) is considered first-line drug in treatment of generalized idiopathic seizures such as absence, generalized tonic-clonic and myoclonic seizures. Among major antiepileptic drugs, VPA is also considered effective in childhood epilepsies and infantile spasms. Due to its broad activity, VPA acts as a mood stabilizer in bipolar disorder and it is useful in migraine prophylaxis. Despite its long-standing usage, severe reactions to VPA, such as liver toxicity and teratogenicity, are reported. To circumvent side effects due to structural characteristics of VPA, we synthesized in good yield a new VPA-aminoacid conjugate, the N-valproyl-L-Phenylalanine, and characterized by FT-IR, …

MaleDrugCell Membrane PermeabilityAminoacidic derivative Astrocytes toxicity CNS-Targeting Enzymatic Stability Hippocampal epilepsy Valproic acid.Cell Survivalmedicine.drug_classPhenylalaninemedicine.medical_treatmentmedia_common.quotation_subjectPrimary Cell CulturePhenylalaninePharmacologySettore BIO/09 - FisiologiaHippocampusTissue Culture TechniquesDrug StabilityDrug DiscoverymedicineAnimalsRats WistarEvoked Potentialsmedia_commonValproic AcidChemistryHydrolysisValproic AcidBiological TransportMood stabilizerMicrotomyHydrogen-Ion ConcentrationIn vitroRatsAnticonvulsantSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoAstrocytesToxicityAnticonvulsantslipids (amino acids peptides and proteins)Conjugatemedicine.drug
researchProduct